4//SEC Filing
Masuoka Lorianne 4
Accession 0000899243-20-027417
CIK 0001478121other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 8:33 PM ET
Size
8.5 KB
Accession
0000899243-20-027417
Insider Transaction Report
Form 4
Pfenex Inc.PFNX
Masuoka Lorianne
Director
Transactions
- Disposition from Tender
Stock Option (right to buy)
2020-10-01−18,000→ 0 totalExercise: $6.43Exp: 2030-05-08→ Common Stock (18,000 underlying) - Disposition from Tender
Stock Option (right to buy)
2020-10-01−25,000→ 0 totalExercise: $5.95From: 2020-05-08Exp: 2029-08-07→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]Upon the terms and subject to the conditions set forth in the Merger Agreement, each option with an exercise price equal to or less than the Cash Portion that remains outstanding as of immediately prior to the Effective Time, whether vested or unvested, will be cancelled and converted into a right to receive, with respect to each share of Issuer Common stock subject to such option, an amount in cash, without interest, equal to the excess, if any, of (i) the Cash Portion over the per share exercise price of such option, plus (ii) the CVR Portion (the "Option Consideration"). All Option Consideration will be paid without interest and less any applicable tax withholdings.
- [F2]One hundred percent (100%) of the shares subject to the option shall vest and become exercisable on the date of the next annual meeting of the Issuer's stockholders (the "Annual Meeting") held after May 8, 2020, subject to the reporting person's continuing service through the date of the Annual Meeting. Notwithstanding the foregoing, one hundred percent (100%) of the shares subject to the option shall vest and become exercisable as of immediately prior to a Change in Control (as such term is defined in the Issuer's 2014 Equity Incentive Plan).
Documents
Issuer
Pfenex Inc.
CIK 0001478121
Entity typeother
Related Parties
1- filerCIK 0001782112
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 8:33 PM ET
- Size
- 8.5 KB